Supplementary Figure S5 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation

2026 Open access

Read full text
Authors: Feven Tameire, Paulina M. Wojnarowicz, Crissy Dudgeon, Kathryn T. Bieging-Rolett, Sho Fujisawa, Savi Ramurthy, Owen Reilly, Christopher G. Thomson, Bradley S. Sherborne, Simon J. Taylor, Fang He, Pengwei Pan
+7 more Baozhong Li, Earl W. May, Alan C. Rigby, Mark J. Mulvihill, Nandita Bose, David Surguladze, Eric S. Lightcap
DOI: 10.1158/1535-7163.30986225
Cited by: 0

Abstract

Western blot analyses for GCN2/ISR pathway proteins in MOLM-16 cells treated with GCN2-targeting agents in combination with halofuginone

Fields of Study & Subjects

Protein Degradation and Inhibitors Melanoma and MAPK Pathways Cancer Mechanisms and Therapy

Publication details

Publisher
American Association for Cancer Research (AACR)
Publication date
2 January 2026